Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics

Conditions: Acute Myeloid Leukemia Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials